Cambridge Cancer Research Hospital unveiled to property chiefs

26 Feb, 2025
Newsdesk
Healthcare insiders call it the hospital that will change the cancer story for ever. The transformational facility concerned is the new Cambridge Cancer Research Hospital (CCRH).
Thumbnail
Image courtesy – NBBJ

And leading figures in the Cambridge property community were given the inside story of the development at an event at Mantle’s Bradfield Centre on Cambridge Science Park ahead of fundraising efforts. 

Two-thirds of the hospital’s £300 million funding will come from the Government and one-third from philanthropy – with the Addenbrooke's Charitable Trust (ACT) committing to raising £14 million through local donations to support the project.

Mantle CEO Guy Baker, who was invited to get involved in the project by the ACT fundraising committee, said: “The CCRH will directly contribute to a once-in-a-generation step change in the way the world approaches cancer diagnosis and treatment.

“That’s why we’re hoping the Cambridge property community will get behind the project with philanthropic support. After all, one in two of us will get cancer at some stage in our lives – so it touches everyone.

“Half of people diagnosed with cancer today could potentially have been diagnosed seven years ago. Think how easier their treatment, higher their survival rate and lower the cost would have been if they’d been diagnosed that long ago.

“We also need to harness genetic data and AI analysis to develop much more precise and tailored treatments that are more effective and have fewer side effects.”

Health Secretary Wes Streeting gave the go-ahead last month for construction work to start in 2026 – with the hospital due to open in 2029.

The CCRH is a collaboration between the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust. It will combine NHS clinical space with three new state-of-the-art research institutes.

The aim is to accelerate the early detection of cancer and prevention of illness, and lead the way in delivering bespoke, precision treatments that will radically improve patient outcomes – not just in Cambridge and the rest of the UK but also worldwide.